Moomoo AI 已提取核心訊息
Kynam Capital Management, LP, along with its general partner Kynam Capital Management GP, LLC, and Yue Tang, have filed a Schedule 13G with the United States Securities and Exchange Commission on January 10, 2024, indicating a significant ownership stake in Burning Rock Biotech Limited. The filing, dated December 31, 2023, reveals that the entities collectively hold 8,694,426 Class A Ordinary Shares, representing 10.19% of the class. The shares are reported to be beneficially owned with both sole and shared voting and dispositive power. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the company. Burning Rock Biotech Limited, headquartered in Guangzhou, China, is the issuer of the securities in question. Kynam Capital Management and its associated entities are organized under the laws of Delaware, with Yue Tang, a U.S. citizen, serving as the Managing Member.
Kynam Capital Management, LP, along with its general partner Kynam Capital Management GP, LLC, and Yue Tang, have filed a Schedule 13G with the United States Securities and Exchange Commission on January 10, 2024, indicating a significant ownership stake in Burning Rock Biotech Limited. The filing, dated December 31, 2023, reveals that the entities collectively hold 8,694,426 Class A Ordinary Shares, representing 10.19% of the class. The shares are reported to be beneficially owned with both sole and shared voting and dispositive power. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the company. Burning Rock Biotech Limited, headquartered in Guangzhou, China, is the issuer of the securities in question. Kynam Capital Management and its associated entities are organized under the laws of Delaware, with Yue Tang, a U.S. citizen, serving as the Managing Member.
Kynam Capital Management, LP及其普通合夥人Kynam Capital Management GP, LLC和Yue Tang已於2024年1月10日向美國證券交易委員會提交了附表13G，表示擁有Burning Rock Biotech Limited的大量所有權。這份日期爲2023年12月31日的文件顯示，這些實體共持有8,694,426股A類普通股，佔該類別的10.19％。據報道，這些股票是實益擁有的，具有唯一和共享的投票權和處置權。文件顯示，這些股份是在正常業務過程中收購的，不是爲了影響公司的控制權。總部位於中國廣州的燃石生物技術有限公司是有關證券的發行人。Kynam Capital Management及其關聯實體根據特拉華州法律組建，管理成員爲美國公民 Yue Tang。
Kynam Capital Management, LP及其普通合夥人Kynam Capital Management GP, LLC和Yue Tang已於2024年1月10日向美國證券交易委員會提交了附表13G，表示擁有Burning Rock Biotech Limited的大量所有權。這份日期爲2023年12月31日的文件顯示，這些實體共持有8,694,426股A類普通股，佔該類別的10.19％。據報道，這些股票是實益擁有的，具有唯一和共享的投票權和處置權。文件顯示，這些股份是在正常業務過程中收購的，不是爲了影響公司的控制權。總部位於中國廣州的燃石生物技術有限公司是有關證券的發行人。Kynam Capital Management及其關聯實體根據特拉華州法律組建，管理成員爲美國公民 Yue Tang。
有用
沒用